多种样本的集合。《投资者网》蔡俊医药板块上市公司,又掀拆分上市浪潮。截至目前,拆分潮涉及的上市公司有四环医药、同仁堂、复星医药、康哲药业、东诚药业。从各家运作的路径看,覆盖“A拆H”、“H拆H”等两条,核心逻辑是行业竞争的升级。但需要指出,此轮再度掀起的拆分潮,背后也浮现出各家上市公司现金紧张、债务承压、主营业务触及“天花板”等深层次原因,与2020年前后诉求多元化扩张的那次拆分潮有本质区别。闯关...
Source Link多种样本的集合。《投资者网》蔡俊医药板块上市公司,又掀拆分上市浪潮。截至目前,拆分潮涉及的上市公司有四环医药、同仁堂、复星医药、康哲药业、东诚药业。从各家运作的路径看,覆盖“A拆H”、“H拆H”等两条,核心逻辑是行业竞争的升级。但需要指出,此轮再度掀起的拆分潮,背后也浮现出各家上市公司现金紧张、债务承压、主营业务触及“天花板”等深层次原因,与2020年前后诉求多元化扩张的那次拆分潮有本质区别。闯关...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.